Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
https://www.zacks.com/stock/news/2270054/halozyme-therapeutics-halo-q1-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2270054
May 07, 2024 - The headline numbers for Halozyme Therapeutics (HALO) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Halozyme Therapeutics (HALO) Q1 Earnings Beat Estimates
https://www.zacks.com/stock/news/2269973/halozyme-therapeutics-halo-q1-earnings-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2269973
May 07, 2024 - Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 14.49% and 2.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
0
Pages: 1
Page 1